Pfizer-BioNTech was said to have won a contract with the Philippines for the supply of the COVID-19 vaccine. It was reported that the country just signed a deal with the American multinational pharmaceutical and biotechnology company for 40 million doses of the vaccines.
The Philippines and Pfizer deal for coronavirus shots
As per Reuters, this is so far the biggest order of Pfizer COVID-19 vaccine from the Philippines. Secretary Carlito Galvez, the National Task Force chief against coronavirus, announced the deal with Pfizer on Sunday, June 20, and revealed that deliveries could be expected to begin in August.
In addition to this new order from Pfizer-BioNTech, the Philippines has now secured the delivery of 113 million doses of vaccine from five suppliers that include China's Sinovac (26 million doses), Moderna (20 million), Russia's Sputnik V (10 million) and AstraZeneca (17 million).
The vaccine supply in Manila is still limited and in some provinces, the government recorded a surge in COVID-19 cases, which complicates efforts to work up on the immunization drive. But with the upcoming Pfizer supply, officials are hoping that it will reach more people and eventually lessen the cases.
“We are very happy to report that the government and the management of Pfizer have finally concluded our negotiations, Philippine News Agency quoted Galvez as saying. “Health Secretary Francisco Duque and I signed yesterday (Saturday, June 19) the supply agreement for the biggest and most decisive deal we had for 2021.”
More vaccine jabs for the Filipinos
Galvez added that 20 million Filipinos will benefit from this Pfizer COVID-19 supply deal. The Philippines is not just waiting for deliveries from the American biotech company, but it is also expecting deliveries from the COVAX facility. In addition, a total of 16 million doses are coming from Jonhson & Johnson and Novavax as well.
Meanwhile, the Philippines will be allowing the administration of the Pfizer-BioNTech vaccines to youngsters ages 12 to 15. Their inoculation may begin later this year once the vaccine inventory expands and the priority group’s vaccinations are completed.


Canada Unveils Bill to Fast-Track Major Resource Projects
SoftBank Launches $11 Billion Bond Sale to Fund OpenAI Investment
US-China Talks Target AI, Tariffs Ahead of Trump-Xi Summit
Gold Prices Slip as Strong Dollar and Hawkish Fed Pressure Bullion
U.S. Stock Futures Rise Ahead of Trump-Xi Summit, Middle East Risks Weigh
Wall Street Mixed as Treasury Yields Rise After Fed Hike
Paramount-Warner Bros $110 Billion Deal Draws Antitrust Backlash
OpenAI Urges US-Led Global Standards for Frontier AI
Allegro Raises 2026 Outlook as International GMV Surges
Volkswagen Shares Slide After 2026 Profit Outlook Cut
US Northeast Airports Resume Operations After Telecom Outage Disrupts Thousands of Flights
UK Home Asking Prices Rise for First Time Since May
France Debt-to-GDP Ratio Seen Hitting Record 119.3% in 2026
Telix to Acquire Germany’s ITM in $1.65 Billion Radiopharma Deal
Fed Rate Hike Threatens Housing as U.S. Growth Leans on AI, Citi Says
CNN, MS NOW and Politico Sue Trump Over White House Media Ban
White House Bars CNN, MS NOW and Politico Reporters 



